World's Best Scientists 2026 revealed!
Christoph Wanner

Christoph Wanner

D-Index & Metrics

Medicine

D-Index
123
Citations
54287
World Ranking
3362
National Ranking
181

Overview

Christoph Wanner is affiliated with the University of Würzburg in Germany. Their research primarily centers on the fields of Medicine with specific emphasis on Endocrinology, Diabetes and Metabolism, Nephrology, Cardiology and Cardiovascular Medicine, Surgery, and Molecular Biology.

Their work covers multiple main topics including Diabetes Treatment and Management, Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management, Pancreatic Function and Diabetes, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, as well as Blood Pressure and Hypertension Studies.

Wanner's recent notable publications include:

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice (2021, European Heart Journal)
  • Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (2020, New England Journal of Medicine)
  • 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (2023, Journal of Hypertension)
  • Empagliflozin in Patients with Chronic Kidney Disease (2022, New England Journal of Medicine)
  • KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2022, Kidney International)

Frequent co-authors in Wanner's research include Bernard Zinman, Silvio E. Inzucchi, Kitty J. Jager, Christiane Drechsler, and Nicholas C Chesnaye.

Wanner has published extensively across a variety of scientific journals, with frequent contributions to:

  • Nephrology Dialysis Transplantation
  • Clinical Kidney Journal
  • Journal of the American Society of Nephrology
  • Kidney International
  • Circulation

Best Publications

  • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson

  • KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    Ian H. de Boer;M. Luiza Caramori;Juliana C.N. Chan;Hiddo J.L. Heerspink

  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    Jane Armitage;Colin Baigent;Elizabeth Barnes;D John Betteridge

  • Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism

    T. Alp Ikizler;Noel J. Cano;Harold Franch;Denis Fouque

  • Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

    G. Eiriksdottir;T. B. Harris;L. J. Launer;V. Gudnason

  • How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

    Silvio E Inzucchi;Bernard Zinman;David Fitchett;Christoph Wanner

  • Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy Evidence for a Better Outcome With Early Treatment

    Frank Weidemann;Markus Niemann;Frank Breunig;Sebastian Herrmann

  • Females with Fabry disease frequently have major organ involvement : Lessons from the Fabry Registry

    William R. Wilcox;William R. Wilcox;João Paulo Oliveira;Robert J. Hopkin;Alberto Ortiz

  • The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.

    Jean-Charles Fruchart;Frank Sacks;Michel P Hermans;Gerd Assmann

  • CKD Prevalence Varies across the European General Population

    Katharina Brück;Vianda S. Stel;Giovanni Gambaro;Stein Hallan

  • Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry Disease A Prospective Strain Rate Imaging Study

    Frank Weidemann;Frank Breunig;Meinrad Beer;Joern Sandstede

  • Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.

    Christine M Eng;Dominique P Germain;Maryam Banikazemi;David G Warnock

  • Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

    Peter Willeit;Peter Willeit;Paul M Ridker;Paul J Nestel;John Simes

  • SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials

    Silvio E Inzucchi;Bernard Zinman;Christoph Wanner;Roberto Ferrari

  • Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

    Christoph Wanner;John M. Lachin;Silvio E. Inzucchi;David Fitchett

  • KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient.

    Christoph Wanner;Marcello Tonelli

  • Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.

    Kitty J. Jager;Anneke Kramer;Nicholas C. Chesnaye;Cécile Couchoud

  • Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

    B. Kasiske;F.G. Cosio;J. Beto;K. Bolton

  • Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial

    David Z I Cherney;David Z I Cherney;Bernard Zinman;Silvio E Inzucchi;Audrey Koitka-Weber

  • Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Iain C. Macdougall;Andreas J. Bircher;Kai Uwe Eckardt;Gregorio T. Obrador

Frequent Co-Authors

Winfried März
Winfried März Medical University of Graz
Silvio E. Inzucchi
Silvio E. Inzucchi Yale University
Bernard Zinman
Bernard Zinman University of Toronto
David G. Warnock
David G. Warnock University of Alabama at Birmingham
Eberhard Ritz
Eberhard Ritz Heidelberg University
Friedo W. Dekker
Friedo W. Dekker Leiden University Medical Center
Kitty J. Jager
Kitty J. Jager University of Amsterdam
Kai-Uwe Eckardt
Kai-Uwe Eckardt Charité - University Medicine Berlin
Georg Ertl
Georg Ertl University of Würzburg
Alberto Ortiz
Alberto Ortiz Autonomous University of Madrid

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring alternatives or specialized career tracks within medicine, accredited online degrees offer flexible routes to advance in the healthcare field. Many professionals are looking to accelerate their career progress through programs that can be completed efficiently and affordably.

For nurses aiming for leadership, a fastest dnp online program allows working professionals to earn their Doctor of Nursing Practice without interrupting their employment. Those concerned about tuition costs can also consider cheapest online dnp programs which make advanced nursing education more accessible.

Students seeking an earlier entry into patient care may benefit from lpn programs that offer streamlined pathways to become Licensed Practical Nurses in less time, often entirely online. Additionally, mental health professionals can broaden their expertise by choosing specialized routes such as psych np programs—ideal for those who wish to focus on psychiatric and mental health nursing.

Exploring these online degree options can help you find a program that matches your career ambitions, timeline, and budget.

Best Scientists Citing Christoph Wanner

Trending Scientists

Recently Published Articles